NCT07272837
- Conditions
- Body Weight, Diabetes, Diabetes Mellitus, +14 more
- Locations
-
- Mazankowski Alberta Heart Institute Edmonton, Alberta, Canada
Clinical trial condition
GLP-1
Explore clinical trials studying GLP-1. Study availability and eligibility vary by location and protocol.
21 public trials
8 recruiting studies
GLP-1 trial results
NCT07605572
- Conditions
- Cornea, Corneal Diseases, Diabete Mellitus, +13 more
- Locations
-
- 2nd Department of Internal Medicine, Research Institute and Diabetes Center, National and Kapodistrian University of Athens, Athens, GRC. Athens, Greece
NCT07572513
- Conditions
- Blood Glucose, GLP-1, Healthy Participant Study, +2 more
- Locations
-
- Clinical Research Center at Purdue University West Lafayette, Indiana, United States
NCT07437911
- Conditions
- GLP-1, Gastrointestinal Microbiome, Nutrition Intake, +1 more
- Locations
-
- Citruslabs Santa Monica, California, United States
NCT07422987
- Conditions
- Body Composition, Estrogen Level, GLP-1, +1 more
- Locations
-
- The University of Kansas Medical Center Kansas City, Kansas, United States
- Conditions
- GLP-1, Nutrition
- Locations
-
- Klinika Diabetologii i Chorób Wewnętrznych Uniwersyteckiego Centrum Klinicznego Warszawskiego Uniwersytetu Medycznego Warsaw, Warszawa, Poland
Recruiting
Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity
NCT07042672
- Conditions
- Binge Eating Disorder, Binge Eating Disorder Associated With Obesity, Binge-Eating Disorder, +16 more
- Locations
-
- Haukeland University Hospital Bergen, Vestland, Norway
NCT07092618
- Conditions
- Aging, GLP-1, Geroscience, +1 more
- Locations
-
- AgelessRx Chicago, Illinois, United States
Not Yet Recruiting
Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer
NCT07314528
- Conditions
- Body Weight, GLP-1, Locally Advanced Rectal Cancer (LARC), +10 more
- Locations
-
Not specified
Not Yet Recruiting
Impact of Probiotic (UltraFlora® Triplebiotic) on Weight Evolution on People After Discontinuation of GLP-1 Treatment.
NCT07209046
- Conditions
- Adults, GLP-1
- Locations
-
Not specified